Results of Combined Medical and Swallowing Behavioral Readjustment Therapy in Oropharyngeal Dysphagia Management Among Parkinson's Patients
Evaluation of the Results of Combined Medical and Swallowing Behavioral Readjustment Therapy in Oropharyngeal Dysphagia Management Among Parkinson's Patients
1 other identifier
interventional
32
1 country
1
Brief Summary
The study aims to assess the efficacy of using swallowing behavioral readjustment technique in combination with medical treatment in management of oropharyngeal dysphagia among Parkinson's patients in order to improve the management protocol
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 30, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 30, 2024
CompletedFirst Submitted
Initial submission to the registry
May 25, 2026
CompletedFirst Posted
Study publicly available on registry
June 1, 2026
CompletedJune 1, 2026
August 1, 2023
1 year
May 25, 2026
May 25, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Fiberoptic Endoscopic Evaluation of Swallowing
Fiberoptic Endoscopic Evaluation of Swallowing involves passing a flexible endoscope through the nose to visualize the swallowing process directly. It allows for a detailed assessment of the structures involved in swallowing and can detect abnormalities or dysfunctions, such as reduced laryngeal elevation or penetration/ aspiration events .
6 months
Secondary Outcomes (1)
Complications as bleeding
6 months
Study Arms (2)
Group (A)
EXPERIMENTALPatients managed by combined pharmaceutical treatment and rehabilitation techniques for 6 months .
Group (B)
EXPERIMENTALPatients managed by pharmaceutical treatment only
Interventions
Group (A) managed by combined pharmaceutical treatment and rehabilitation techniques for 6 months .
Eligibility Criteria
You may qualify if:
- Patients with parkinson's disease based on established diagnostic criteria complaining of oropharyngeal dysphagia.
You may not qualify if:
- Other significant medical conditions: Participants with significant medical conditions that could confound the assessment of dysphagia or its causes may be excluded.
- Prior surgical interventions or interventions affecting swallowing.
- Cognitive impairment: Parkinson's patients with severe cognitive impairments
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Tanta Universitylead
Study Sites (1)
Tanta University
Tanta, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Resident
Study Record Dates
First Submitted
May 25, 2026
First Posted
June 1, 2026
Study Start
August 30, 2023
Primary Completion
August 30, 2024
Study Completion
August 30, 2024
Last Updated
June 1, 2026
Record last verified: 2023-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
It will be available if it needed